Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

1.0%

2 terminated/withdrawn out of 204 trials

Success Rate

93.9%

+7.4% vs industry average

Late-Stage Pipeline

16%

32 trials in Phase 3/4

Results Transparency

1 of 31 completed trials have results

Key Signals

74 recruiting1 with results

Enrollment Performance

Analytics

N/A

64(44.8%)

Phase 2

40(28.0%)

Phase 3

23(16.1%)

Phase 4

9(6.3%)

Phase 1

4(2.8%)

Early Phase 1

3(2.1%)

143Total

N/A(64)

Phase 2(40)

Phase 3(23)

Phase 4(9)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (204)

Showing 20 of 204 trials

NCT07561892Phase 4Recruiting

Study of the Effectiveness and Safety of Daunorubicin /Idarubicin ± Silibinin in Treating Newly Diagnosed AML (Non-M3).

Role: lead

NCT07551037Phase 1Recruiting

Efficacy and Safety of Autologous Peptide-induced Active Immunity in AML Maintenance Therapy

Role: lead

NCT07541755Phase 3Active Not Recruiting

PD-1 Inhibitors +Venetoclax+CAG Regimens in R/R T-ALL

Role: lead

NCT07541521Recruiting

RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC

Role: collaborator

NCT07533825Not ApplicableEnrolling By Invitation

Laparoscopic Staging for Stage III Gastric Cancer

Role: collaborator

NCT07528066Recruiting

Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC

Role: collaborator

NCT06790810Completed

Observational Study on Dynamic Changes of Blood Pressure During Post-epileptic Seizure Stage (OCBPS)

Role: collaborator

NCT07493070Not ApplicableActive Not Recruiting

Ultra-stable Iodized Oil-Chemo Embolization Seq Thermal Ablation in Early Liver Ca

Role: lead

NCT03657732Recruiting

The Chinese Familial Alzheimer's Network

Role: collaborator

NCT03653156Recruiting

China Cognition and Aging Study

Role: collaborator

NCT05029141Phase 2Active Not Recruiting

New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Role: collaborator

NCT06265051Phase 2Completed

Tirofiban After Successful MT Recanalization in AIS

Role: collaborator

NCT07444983Not ApplicableNot Yet Recruiting

Rezvilutamide for High-Risk Prostate Cancer After Surgery

Role: lead

NCT07406815Phase 3Not Yet Recruiting

The Value of Near-Infrared Fluorescence Imaging in the Protection of the Recurrent Laryngeal Nerve During Minimally Invasive Esophagectomy

Role: lead

NCT07398911Not ApplicableEnrolling By Invitation

3-Dimensional Simulation Guided Transcatheter Aortic Valve Replacement in Aortic Regurgitation(DIGITAL)

Role: collaborator

NCT07383142Not ApplicableNot Yet Recruiting

Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence (CHOICE-2)

Role: collaborator

NCT07389889Not ApplicableNot Yet Recruiting

Percutaneous Robotic Navigation Microwave Ablation Versus CT-guided Microwave Ablation in the Treatment of Pulmonary Nodules With Ground-glass Opacity

Role: lead

NCT07382375Not ApplicableNot Yet Recruiting

AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection

Role: collaborator

NCT07373054Not ApplicableRecruiting

Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Androgenic Alopecia

Role: lead

NCT06677931Not ApplicableCompleted

Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Melasma

Role: lead